| 2.02 0.09 (4.66%) | 04-24 14:37 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.92 | 1-year : | 1.06 |
| Resists | First : | 0.79 | Second : | 0.91 |
| Pivot price | 0.67  |
|||
| Supports | First : | 0.6 | Second : | 0.5 |
| MAs | MA(5) : | 0.63  |
MA(20) : | 0.69 |
| MA(100) : | 0.88 |
MA(250) : | 0.98 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 16 |
D(3) : | 13.2 |
| RSI | RSI(14): 35.2 |
|||
| 52-week | High : | 1.62 | Low : | 0.6 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CLOV ] has closed above bottom band by 36.1%. Bollinger Bands are 40.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 0.64 - 0.64 | 0.64 - 0.65 |
| Low: | 0.6 - 0.61 | 0.61 - 0.61 |
| Close: | 0.62 - 0.63 | 0.63 - 0.63 |
Tue, 12 Mar 2024
Clover Health Investments, Corp. (CLOV) Q4 2023 Earnings Call Transcript - Seeking Alpha
Mon, 04 Dec 2023
Insurtech company Clover Health will exit the ACO REACH program - Mobihealth News
Thu, 17 Aug 2023
CLOV: Buy, Sell or Hold: What Should Investors Do With Clover Health Investments (CLOV)? - StockNews.com
Sun, 09 Jul 2023
Clover Health Is Down 68% In 1 Year, But Wall Street Is Predicting It'll Rise by 70%. Should You Buy It? - The Motley Fool
Fri, 19 May 2023
$22M Clover Health settlement resolves claims insurance provider covered up DOJ probe - Top Class Actions
Mon, 24 Apr 2023
Clover Health's stock could be delisted from the Nasdaq, company says - Fierce healthcare
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 406 (M) |
| Shares Float | 375 (M) |
| Held by Insiders | 7.3 (%) |
| Held by Institutions | 24.4 (%) |
| Shares Short | 43,980 (K) |
| Shares Short P.Month | 36,540 (K) |
| EPS | -0.44 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.58 |
| Profit Margin | -10.5 % |
| Operating Margin | -10.4 % |
| Return on Assets (ttm) | -17 % |
| Return on Equity (ttm) | -66.4 % |
| Qtrly Rev. Growth | -44.3 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 5.02 |
| EBITDA (p.s.) | -0.46 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -116 (M) |
| Levered Free Cash Flow | 72 (M) |
| PE Ratio | -1.47 |
| PEG Ratio | -0.2 |
| Price to Book value | 1.09 |
| Price to Sales | 0.12 |
| Price to Cash Flow | -2.27 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|